Osteoblast Lineage Cell-derived Sema3A Regulates Bone Homeostasis Independently of Androgens

Endocrinology. 2022 Oct 1;163(10):bqac126. doi: 10.1210/endocr/bqac126.


Semaphorin 3A (Sema3A) coordinates bone resorption and formation under the control of estrogen signaling. However, the contribution of osteoblast lineage cell-derived Sema3A to vertebral homeostasis has remained unclear. Moreover, it is unknown whether androgen signaling is involved in Sema3A expression in osteoblast lineage cells. In this study, we show that osteoblast lineage cell-derived Sema3A plays a key role in bone homeostasis independent of androgen signaling. Sema3a deletion with Sp7-Cre did not alter the trabecular bone mass in lumbar vertebrae, along with there being no significant difference in Sema3a mRNA expression. In contrast, osteoblast lineage cell-specific deletion of Sema3A with BGLAP-Cre led to decreased bone volume in both long bones and lumbar vertebrae. In addition, osteoblast lineage cell-derived Sema3A was not involved in orchidectomy-induced bone loss because androgen deficiency did not affect Sema3A protein expression. Thus, these results indicate that Sema3A derived from osteoblast lineage cells acts as an osteoprotective factor, even in vertebrae, and its expression is controlled in an androgen-independent manner.

Keywords: Sema3A; androgen; osteoblast; osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgens* / pharmacology
  • Bone and Bones / metabolism
  • Homeostasis
  • Osteoblasts / metabolism
  • Semaphorin-3A* / genetics
  • Semaphorin-3A* / metabolism


  • Androgens
  • Semaphorin-3A